Publications

Joint publications:
ZORA Publication List
Download Options
Publications
-
New and emerging roles of small RNAs in neurodegeneration, muscle, cardiovascular and inflammatory diseases. Swiss Medical Weekly:w14192.
Table of contents
Aguzzi Group
ZORA Publication List
Download Options
Publications
-
Autoantibodies against the prion protein in individuals with PRNP mutations. Neurology, 95(14):e2028-e2037.
-
Protective anti‐prion antibodies in human immunoglobulin repertoires. EMBO Molecular Medicine:e12739.
-
Genome-wide transcriptomics identifies an early preclinical signature of prion infection. PLoS Pathogens, 16(6):e1008653.
-
NG2 glia are required for maintaining microglia homeostatic state. Glia:glia.23721.
-
Unaltered prion disease in mice lacking developmental endothelial locus–1. Neurobiology of Aging, 76:208-213.
-
SARM1 deficiency up-regulates XAF1, promotes neuronal apoptosis, and accelerates prion disease. Journal of Experimental Medicine:jem.20171885.
-
Genome-Wide Identification of microRNAs Regulating the Human Prion Protein. Brain Pathology, 29(2):232-244.
-
Toxic Protein Spread in Neurodegeneration: Reality versus Fantasy. Trends in Molecular Medicine, 24(12):1007-1020.
-
Prion pathogenesis is unaltered in a mouse strain with a permeable blood-brain barrier. PLoS Pathogens, 14(11):e1007424.
-
Prions, prionoids and protein misfolding disorders. Nature Reviews. Genetics, 19(7):405-418.
-
Intrinsic Toxicity of Antibodies to the Globular Domain of the Prion Protein. Biological Psychiatry, 84(7):e51-e52.
-
GPR56/ADGRG1 regulates development and maintenance of peripheral myelin. Journal of Experimental Medicine, 215(3):941-961.
-
Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity. PLoS Pathogens, 13(11):e1006733.
-
Absolute Quantification of Amyloid Propagons by Digital Microfluidics. Analytical Chemistry, 89(22):12306-12313.
-
Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling. PLoS ONE, 12(5):e0177876.
-
The biological function of the cellular prion protein: an update. BMC Biology, 15:34.
-
Modifiers of prion protein biogenesis and recycling identified by a highly-parallel endocytosis kinetics assay. Journal of Biological Chemistry, 292(20):8356-8368.
-
Cystatin F is a biomarker of prion pathogenesis in mice. PLoS ONE, 12(2):e0171923.
-
Neurotoxic antibodies against the prion protein do not trigger prion replication. PLoS ONE, 11(9):e0163601.
-
The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6. Nature, 536(7617):464-468.
-
A neuroprotective role for microglia in prion diseases. Journal of Experimental Medicine, 213(6):1047-1059.
-
Phase separation: linking cellular compartmentalization to disease. Trends in Cell Biology, 26(7):547-558.
-
Differential toxicity of antibodies to the prion protein. PLoS Pathogens, 12(1):e1005401.
-
Strictly co-isogenic C57BL/6J-Prnp−/−mice: A rigorous resource for prion science. Journal of Experimental Medicine, 213(3):313-327.
-
Cell biology of prions and prionoids: a status report. Trends in Cell Biology, 26(1):40-51.
-
Altered monoaminergic systems and depressive-like behavior in congenic prion protein nnock-out mice. Journal of Biological Chemistry, 290(43):26350.
-
Structure-based drug design identifies polythiophenes as antiprion compounds. Science Translational Medicine, 7(299):299ra123.
-
Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways. PLoS Pathogens, 11(2):e1004662.
-
Prion pathogenesis in the absence of NLRP3/ASC inflammasomes. PLoS ONE, 10(2):e0117208.
-
Neurodegeneration: Alzheimer's disease under strain. Nature, 512(7512):32-34.
-
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nature Immunology, 15(8):727-737.
-
The role of the NADPH oxidase NOX2 in prion pathogenesis. PLoS Pathogens, 10(12):e1004531.
-
The immunobiology of prion diseases. Nature Reviews. Immunology, 13(12):888-902.
-
SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells. Journal of Experimental Medicine, 210(12):2539-2552.
-
The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature, 501(7465):102-106.
-
Prions and lymphoid organs: Solved and remaining mysteries. Prion, 7(2):157-163.
-
Efficient amyloid a clearance in the absence of immunoglobulins and complement factors. American Journal of Pathology, 182(4):1297-1307.
-
Microglia: scapegoat, saboteur, or something else?. Science, 339(6116):156-161.
-
Prions: protein aggregation and infectious diseases. Physiological Reviews, 89(4):1105-1152.
Krützfeldt Group
ZORA Publication List
Download Options
Publications
-
Uncoupling protein 1 expression in adipocytes derived from skeletal muscle fibro/adipogenic progenitors is under genetic and hormonal control. Journal of Cachexia, Sarcopenia and Muscle, 9(2):384-399.
-
Strategies to use microRNAs as therapeutic targets. Best Practice & Research : Clinical Endocrinology & Metabolism, 30(5):551-561.
-
Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance. Journal of Molecular Medicine, 93(12):1369-1379.
Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005 Dec 1;438(7068):685-9.
Krützfeldt J, Poy MN, Stoffel M. Strategies to determine the biological function of microRNAs. Nat Genet. 2006 Jun;38 Suppl 1:S14-9.
Krützfeldt J, Stoffel M. MicroRNAs: A new class of regulatory genes affecting metabolism. Cell Metab. 2006 Jul;4(1):9-12.
Krützfeldt J, Kuwajima S, Braich R, Rajeev KG, Pena J, Tuschl T, Manoharan M, Stoffel M. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 2007 April; 35(9):2885-92.
Krützfeldt J, Rösch N, Hausser J, Manoharan M, Zavolan M, Stoffel M. MicroRNA-194 is a target of transcription factor 1 (Tcf1, Hnf1α) in adult liver and controls expression of frizzled-6. Hepatology. 2012 Jan;55(1):98-107.
Polymenidou Group
ZORA Publication List
Download Options
Publications
-
Prion-like propagation as a pathogenic principle in frontotemporal dementia. Journal of Neurochemistry, 138 Supp:163-183.
Polymenidou M*, Lagier-Tourenne C*, Hutt KR*, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, Kordasiewicz H, Sedaghat Y, Donohue JP, Shiue L, Bennett CF, Yeo GW, Cleveland DW (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature Neurosc, 14, 459–468 [*equal contribution]
Polymenidou M, Cleveland DW (2011) The Seeds of Neurodegeneration: Prion-like Spreading in ALS. Cell, 147, 498-508
Polymenidou M, Cleveland DW (2012) Prion-like spread of protein aggregates in neurodegeneration. Journal of Exp Med, 209, 889-93
Lagier-Tourenne C*, Polymenidou M*, Hutt KR*, Vu AQ, Clutario K, Baughn M, Huelga SC, Ling SC, Liang TY, Mazur C, Wancewicz E, Kim AS, Watt A, Freier S, Hicks GG, Donohue JP, Shiue L, Bennett CF, Ravits J, Cleveland DW and Yeo GW (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nature Neurosc, 15, 1488-97 [*equal contribution]
Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, Qiu J, Sun Y, Ling S-C, Zhu Q, Polymenidou M, Drenner K, Artates JW, McAlonis-Downes M, Markmiller S, Hutt KR, Pizzo DP, Cady J, Harms MB, Baloh RH, Vandenberg SR, Yeo GW, Fu X-D, Bennett CF, Cleveland DW, Ravits J (2013) Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. PNAS, 110, 47, E4530-39
Stoffel Group
LaPierre MP and Stoffel M (2017). MicroRNAs as stress regulators in pancreatic beta cells and diabetes. Molecular Metabolism 6:1010-1023.
Landmesser Group
ZORA Publication List
Download Options
Publications
-
Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2. Journal of the American College of Cardiology, 84(24):2347-2363.
-
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation. New England Journal of Medicine, 391(19):1799-1809.
-
The inflammatory spectrum of cardiomyopathies. Frontiers in Cardiovascular Medicine, 11:1251780.
-
Coronary microevaginations characterize culprit plaques and their inflammatory microenvironment in a subtype of acute coronary syndrome with intact fibrous cap: results from the prospective translational OPTICO-ACS study. European Heart Journal. Cardiovascular Imaging, 25(2):175-184.
-
Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study Group. Nature Reviews. Cardiology, 20(10):696-714.
-
Prognostic impact of fractional flow reserve measurements in patients with acute coronary syndromes: a subanalysis of the FLORIDA study. Heart and Vessels, 38(8):1009-1018.
-
Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome. European Heart Journal, 44(38):3911-3925.
-
Coexistence of calcified- and lipid-containing plaque components and their association with incidental rupture points in acute coronary syndrome-causing culprit lesions: results from the prospective OPTICO-ACS study. European Heart Journal. Cardiovascular Imaging, 23(12):1598-1605.
-
Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology, 80(19):1802-1814.
-
Gender-Specific Performance of One- Compared to Two-Catheter Concepts in Transradial Coronary Angiography - Insights From the Randomized UDDC-Radial-Trial. Cardiovascular Revascularization Medicine, 43:49-54.
-
Vascular endothelial Tissue Factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis. Cardiovascular Research, 118(10):2367-2384.
-
Prognostic Impact of Pancoronary Quantitative Flow Ratio Assessment in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes. Circulation. Cardiovascular Interventions, 14(12):e010698.
-
Reproducible Determination of High-Density Lipoprotein Proteotypes. Journal of Proteome Research, 20(11):4974-4984.
-
Extracellular vesicle species differentially affect endothelial cell functions and differentially respond to exercise training in patients with chronic coronary syndromes. European Journal of Preventive Cardiology, 28(13):1467-1474.
-
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes. Journal of the American Heart Association, 10(20):e020488.
-
Feasibility and diagnostic reliability of quantitative flow ratio in the assessment of non-culprit lesions in acute coronary syndrome. International Journal of Cardiovascular Imaging, 37(6):1815-1823.
-
Impact of real-time angiographic co-registered optical coherence tomography on percutaneous coronary intervention: the OPTICO-integration II trial. Clinical Research in Cardiology, 110(2):249-257.
-
Advancing RNA-targeted therapy for personalised prevention of coronary disease: focus on ANGPLT3. European Heart Journal, 41(40):3946-3948.
-
From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases. European Heart Journal, 41(40):3884-3899.
-
Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes. Catheterization and Cardiovascular Interventions, 96(4):E439-E446.
-
Assessment of intermediate coronary lesions by fractional flow reserve and quantitative flow ratio in patients with small-vessel disease. Catheterization and Cardiovascular Interventions, 96(4):743-751.
-
Myoglobin for Detection of High-Risk Patients with Acute Myocarditis. Journal of Cardiovascular Translational Research, 13(5):853-863.
-
Virome Sequencing in Patients With Myocarditis. Circulation : Heart Failure, 13(7):e007103.
-
Clinical Presentation and Laboratory Findings in Men Versus Women with Myocarditis. Journal of Women's Health, 29(2):193-199.
-
Structure-function relationships of HDL in diabetes and coronary heart disease. Journal of Clinical Investigation Insight, 5(1):131491.
-
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal, 41(1):111-188.
-
Comparison of resting distal to aortic coronary pressure with angiography-based quantitative flow ratio. International Journal of Cardiology, 279:12-17.
-
Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data. Clinical Research in Cardiology, 108(11):1249-1257.
-
Association of the body mass index with outcomes in elderly patients (≥80 years) undergoing percutaneous coronary intervention. International Journal of Cardiology, 292:73-77.
-
Effect on Outcomes: Infections Complicating Percutaneous Coronary Interventions in Patients ≥80 Years of Age. American Journal of Cardiology, 123(11):1806-1811.
-
Pulmonary hypertension in patients with severe aortic stenosis: prognostic impact after transcatheter aortic valve replacement: pulmonary hypertension in patients undergoing TAVR. JACC : Cardiovascular Imaging, 12(4):591-601.
-
Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography. Catheterization and Cardiovascular Interventions, 93(1):16-24.
-
Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. Open Heart, 6(1):e000987.
-
Impact of acute kidney injury in elderly (≥80 years) patients undergoing percutaneous coronary intervention. Journal of Interventional Cardiology, 31(6):792-798.
-
Performance of One- Compared With Two-Catheter Concepts in Transradial Coronary Angiography (from the Randomized Use of Different Diagnostic Catheters-Radial-Trial). American Journal of Cardiology, 122(10):1647-1651.
-
Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes. International Journal of Cardiology, 270:7-13.
-
Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort. European Heart Journal: Acute Cardiovascular Care, 7(6):522-531.
-
Effect of Physical Disability on Mortality in Elderly Patients of ≥80 Years of Age Undergoing Percutaneous Coronary Intervention. American Journal of Cardiology, 122(4):537-541.
-
The danger lurks dastardly in the coronary vessel wall: spotlight on patients' vulnerability. European Heart Journal, 39(18):1656.
-
The predictive value of a modified Carpentier classification in patients with coincidental mitral regurgitation undergoing TAVI for severe aortic valve stenosis1. Clinical Hemorheology and Microcirculation, 70(1):15-25.
-
Transcatheter Aortic Valve Replacement and Concomitant Mitral Regurgitation. Frontiers in Cardiovascular Medicine, 5:74.
-
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes. European Heart Journal, 38(47):3493-3502.
-
Left atrial appendage occlusion in patients with atrial fibrillation and previous major gastrointestinal bleeding (from the Amplatzer Cardiac Plug Multicenter Registry). American Journal of Cardiology, 120(3):414-420.
-
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. European Heart Journal, 38(20):1597-1607.
-
HDL cholesterol: reappraisal of its clinical relevance. Clinical Research in Cardiology, 106(9):663-675.
-
The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis. JACC. Cardiovascular interventions, 10(5):489-499.
-
Intracoronary optical coherence tomography: clinical and research applications and intravascular imaging software overview. Catheterization and Cardiovascular Interventions, 89(4):679-689.
-
Klinische Bedeutung des HDL-Cholesterins. Herz, 42(1):58-66.
-
Increased proangiogenic activity of mobilized CD34$^+$ progenitor cells of patients with acute ST-segment-elevation myocardial infarction: role of differential MicroRNA-378 expression. Arteriosclerosis, Thrombosis, and Vascular Biology, 37(2):341-349.
-
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal, 37(39):2999-3058.
-
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency. European Journal of Heart Failure, 18(5):482-489.
-
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal, 37(3):267-315.
-
EHJ's new impact factor of 15.2: a global strategy is paying off. European Heart Journal, 36(41):2763-2766.
-
Novel methodologies for biomarker discovery in atherosclerosis. European Heart Journal, 36(39):2635-2642.
-
New and emerging roles of small RNAs in neurodegeneration, muscle, cardiovascular and inflammatory diseases. Swiss Medical Weekly:w14192.
-
Circulating FABP4 Is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals. Arteriosclerosis, Thrombosis, and Vascular Biology, 35(8):1872-1879.
-
Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL. Atherosclerosis, 241(2):539-546.
-
Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy. International Journal of Cardiovascular Imaging, 31(5):915-926.
-
2014 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention, 10(9):1024-1094.
-
Dysfunctional HDL: from structure-function-relationships to biomarkers. In: von Eckardstein, Arnold; Kardassis, Dimitris. High Density Lipoproteins : From Biological Understanding to Clinical Exploitation. Berlin Heidelberg New York: Springer, 337-366.
-
N-terminal pro-B-type natriuretic peptide ratio predicts mortality after transcatheter aortic valve replacement. Catheterization and Cardiovascular Interventions, 85(7):1240-1247.
-
Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device. Catheterization and Cardiovascular Interventions, 85(2):306-312.
-
Drug-eluting stents vs. bare metal stents in patients with cardiogenic shock: a comparison by propensity score analysis. Journal of Cardiovascular Medicine, 16(3):220-229.
-
Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes. European Heart Journal, 36(17):1041-1048.
-
High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: Impact on arterial thrombus formation. Thrombosis and Haemostasis, 112(5):1024-1035.
-
2014 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal, 35(37):2541-2619.
-
FastTrack: a key success factor for the European Heart Journal. European Heart Journal, 35(30):1983-1990.
-
High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease. Cardiovascular Research, 103(3):350-361.
-
Neue AHA- und ACC-Leitlinie zur Risikoreduktion von Herz-Kreislauf-Erkrankungen durch Cholesterinsenkung. Der Internist, 55(5):601-606.
-
Catch me if you can. European Heart Journal, 35(14):903.
-
The Year in Cardiology 2013: cardiovascular disease prevention. European Heart Journal, 35(5):307-312.
-
High-density lipoprotein: Vascular protective effects, dysfunction, and potential as therapeutic target. Circulation Research, 114(1):171-182.
-
To do or not to do? Changing paradigms: value of balloon-sizing and left atrial appendage occlusion. Cardiovascular Medicine, 17(1):21-23.
-
2014 ESC/EACTS Guidelines on myocardial revascularization. Kardiologia Polska, 72(12):1253-1379.
-
HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. Journal of the American Society of Nephrology (JASN), 25(11):2658-2668.
-
Transcatheter aortic valve-in-valve implantation: Clinical outcome as defined by VARC-2 and postprocedural valve dysfunction according to the primary mode of bioprosthesis failure. Journal of Invasive Cardiology, 26(10):542-547.
-
Is the panic about beta-blockers in perioperative care justified?. European Heart Journal, 35(36):2442-2444.
-
New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk. Wiener Klinische Wochenschrift, 126(5-6):169-175.
-
Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. European Heart Journal, 35(40):2839-2848.
-
Klinische Effekte der katheterbasierten Nierennervenablation bei therapieresistenter Hypertonie. Cardiovascular Medicine, 17(1):8-13.
-
Novel insights into vascular repair mechanisms. Current Pharmaceutical Design, 20(14):2430-2438.
-
TAVI in a low left main coronary artery ostium and wide aortic sinus of Valsava. European Heart Journal, 35(27):1791.
-
Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. European Journal of Cardio-Thoracic Surgery, 45(1):126-131.
-
Current outcome of acute coronary syndromes: data from the Zurich-Acute Coronary Syndrome (Z-ACS) Registry. Cardiovascular Medicine, 13(4):115-122.
-
Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(6):1392-1400.
-
Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression. Basic Research in Cardiology, 108(4):368.
-
Optical frequency domain imaging for guidance of optimal stenting in the setting of recanalization of chronic total occlusion. Journal of Invasive Cardiology, 25(7):367-368.
-
High-density lipoproteins and endothelial functions: Mechanistic insights and alterations in cardiovascular disease. Journal of Lipid Research, 54(12):3227-3243.
-
Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. Journal of Clinical Investigation, 123(9):3815-3828.
-
High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. European Heart Journal, 34(46):3563-3571.
-
Exercise training in patients with chronic heart failure promotes restoration of HDL functional properties. Circulation Research, 113(12):1345-1355.
-
The difficult search for a 'partner' of statins in lipid-targeted prevention of vascular events: the re-emergence and fall of niacin. European Heart Journal, 34(17):1254-1257.
-
Current status of cell-based therapy for heart failure. Current Heart Failure Reports, 10(2):165-176.
-
Giant unruptured sinus valsalva aneurysm: an unusual cause of typical angina. European Heart Journal, 34(21):1608.
-
The impact of partial and complete loss of function mutations in endothelial lipase on hdl levels and functionality in humans. Circulation. Cardiovascular Genetics, 6(1):54-62.
-
The European Heart Journal on the move: can scientific publishing be further improved?. European Heart Journal, 34(6):409-415.
-
"Endothelial progenitor cells" as a therapeutic strategy in cardiovascular disease. Current Vascular Pharmacology, 10(1):107-124.
-
Optical coherence tomography (OCT) evaluation after coronary stenting: the "black hole" and other low OCT signal-intensity areas. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 7(12):1367-1371.
-
Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease. EMBO Molecular Medicine, 4(4):251-268.
-
Arrhythmogenic cardiomyopathy suspected by electrocardiogram: confirmed by angiography. European Heart Journal, 33(11):1343.
-
Assessment of inflammatory response to transfemoral transcatheter aortic valve implantation compared to transapical and surgical procedures: a pilot study. Journal of Invasive Cardiology, 24(8):407-411.
-
Cardiac quadruple-fusion imaging: a brief report on a novel integrated multimodality approach for in vivo visualization of transplanted stem cells. International journal of cardiology, 161(1):62-63.
-
High Density Lipoprotein - Should we Raise it?. Current Vascular Pharmacology, 10(6):718-719.
-
Interventional treatment of essential hypertension: renal sympathetic denervation. In: Eeckout, E; Serruys, P W; Wijns, W; Vahanian, A; van Sambeek, M R H M; De Palma, R. Percutaneous Interventional Cardiovascular Medicine: The PCR-EAPCI Textbook. Toulouse: Europa Edition, online.
-
The European Heart Journal and the European Journal of Heart Failure: partners in scientific publishing. European Journal of Heart Failure, 14(10):1075-1082.
-
The best of the European Heart Journal: look back with pride. European Heart Journal, 33(10):1161-1171.
-
Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia, 26(1):23-33.
-
Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovascular Research, 93(4):614-622.
-
Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation. European Heart Journal, 33(6):698-704.
-
A novel flow cytometry-based assay to study leukocyte-endothelial cell interactions in vitro. Cytometry. Part A, 79(4):256-262.
-
Deletion of L-selectin increases atherosclerosis development in ApoE-/- mice. PLoS ONE, 6(7):e21675.
-
Review of the field of left atrial appendage occlusion devices. Franco CH096-098, University of Zurich.
-
Stem cells in cardiovascular regeneration: from preservation of endogenous repair to future cardiovascular therapies.. Current Pharmaceutical Design, 17(30):3280-3294.
-
Vascular function of the peripheral and coronary circulation: worthwhile to assess their relation?. Journal of Nuclear Cardiology, 18(2):201-203.
-
Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. International Journal of Developmental Biology, 55(4-5):407-417.
-
Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. European Journal of Cardiovascular Prevention and Rehabilitation, 18(6):775-789.
-
Stem cells in heart failure. Stem Cells International, 2011:193918.
-
Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Seminars in Nephrology, 31(5):433-440.
-
A new look at HDL in coronary disease: can we escape natural history?. Heart, 97(23):1899-1901.
-
Dizziness and pre-syncope: an unusual clinical presentation of a spontaneous coronary artery dissection as revealed by optical coherence tomography. Journal of the American College of Cardiology, 58(11):1191.
-
Exercise training improves in vivo endothelial repair capacity of early endothelial progenitor cells in subjects with metabolic syndrome. European Journal of Cardiovascular Prevention & Rehabilitation, 18(3):406-414.
-
Cardiac hybrid imaging in a patient with a single coronary artery originating from the right sinus of Valsalva. European Heart Journal, 32(22):2757.
-
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. Journal of Clinical Investigation, 121(7):2693-708.
-
Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. European Heart Journal, 32(10):1197-1206.
-
Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade. Journal of the American College of Cardiology, 57(5):601-611.
-
Non-invasive assessment of coronary artery disease with CT coronary angiography and SPECT: a novel dose-saving fast-track algorithm. European Journal of Nuclear Medicine and Molecular Imaging, 37(3):522-527.
-
Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function. Cardiovascular Therapeutics, 28(4):187-201.
-
High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease. Current Pharmaceutical Design, 16(13):1480-1493.
-
Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. European Heart Journal, 31(14):1792-1801.
-
Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation, 122(18):1789-1796.
-
Standing firm - the European Heart Journal, scientific controversies and the industry. European Heart Journal, 31(10):1157-1158.
-
Happy birthday European Heart Journal: in 30 years, from Cinderella to centre stage. European Heart Journal, 31(16):1945-1950.
-
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. European Heart Journal, 31(18):2301-2309.
-
Severe left main coronary stenosis and mitral regurgitation in a young female patient without cardiovascular risk factors 14 years after mediastinal radiation therapy. Clinical Research in Cardiology, 99(3):199-201.
-
Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 179(10):939-949.
-
Determinants of vessel contrast in BMI-adapted low dose CT coronary angiography with prospective ECG-triggering. The International Journal of Cardiovascular Imaging, 25(6):625-630.
-
Potential novel pharmacological therapies for myocardial remodelling. Cardiovascular Research, 81(3):519-527.
-
The European Heart Journal goes global: the road ahead of the editorial team 2009-2011. European Heart Journal, 30(1):1-5.
-
Bone marrow cell therapy after myocardial infarction. What should we select?. European Heart Journal, 30(11):1310-1312.
-
Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome. JAMA: The Journal of the American Medical Association, 302(11):1210-1217.
-
Low-dose computed tomography coronary angiography and myocardial perfusion imaging: cardiac hybrid imaging below 3mSv. European Heart Journal, 30(6):644.
-
Ex vivo expanded haematopoietic progenitor cells improve dermal wound healing by paracrine mechanisms. Experimental Dermatology, 18(5):445-453.
-
Accuracy of low-dose computed tomography coronary angiography using prospective electrocardiogram-triggering: first clinical experience. European Heart Journal, 29(24):3037-3042.
-
Uric acid in chronic heart failure - current pathophysiological concepts. European Journal of Heart Failure, 10(12):1269-1270.
-
Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. American Journal of Pathology, 173(4):915-926.
-
Pharmacological approaches to improve endothelial repair mechanisms. Expert Review of Cardiovascular Therapy, 6(8):1071-1082.
-
Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner. Journal of Hypertension, 26(2):257-268.
-
Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose. Journal of Molecular and Cellular Cardiology, 45(3):394-403.
-
Endothelial dysfunction as an early sign of atherosclerosis. Herz, 32(7):568-572.
-
Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure. European Journal of Heart Failure, 9(8):770-775.
Shroff, R. et al. HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype. Journal of the American Society of Nephrology : JASN 25, 2658-2668, doi:10.1681/ASN.2013111212 (2014).
Landmesser, U. Coronary artery disease: HDL and coronary heart disease--novel insights. Nature reviews. Cardiology 11, 559-560, doi:10.1038/nrcardio.2014.128 (2014).
Kratzer, A., Giral, H. & Landmesser, U. High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease. Cardiovascular research 103, 350-361, doi:10.1093/cvr/cvu139 (2014).
Krankel, N., Luscher, T. F. & Landmesser, U. Novel insights into vascular repair mechanisms. Current pharmaceutical design 20, 2430-2438 (2014).
Kyburz Group
Kyburz D, Karouzakis E, Ospelt C. Epigenetic changes: the missing link. Best Pract Res Clin Rheumatol. 2014 Aug;28(4):577-587.